Submission deadline: March 18, 2024 @ 23:59 EST
Extended to April 5, 2024 @ 23:59 EDT (Late submissions will be accepted until Monday, April 8 @ 08:00 EDT)
Extended to April 5, 2024 @ 23:59 EDT (Late submissions will be accepted until Monday, April 8 @ 08:00 EDT)
Submitting an abstract to the TTS 2024 Congress offers a platform to showcase groundbreaking research, connect with global experts, and contribute to advancements in transplantation medicine, fostering collaboration and influencing the field's future direction.
New! Design a Studio Session
We're seeking fresh, imaginative ideas for smaller sessions that will ignite inspiration and foster meaningful discussions among participants. Whether it's a workshop, a panel discussion, or a hands-on creative activity, we want to hear your suggestions! These sessions will be hosted in one of our four studios with a maximum capacity of 40 to 60 participants.
Program Update - Dec 15, 2023
Under the banner of Inform, Transform, Sustain TTS 2024 will facilitate a holistic and comprehensive exploration of the interconnected aspects of the field of transplantation.
About the themes:
- Inform - encompasses updates on research, clinical practices, and technological advancements.
- Transform - focuses on innovative techniques, new treatment modalities, and transformative approaches to transplantation.
- Sustain - emphasizes long-term outcomes, ethical considerations, sustainability, and global accessibility of transplantation services.
The program offers delegates:
- Multidimensional learning experience - Participants will explore scientific, clinical, ethical, social, and economic aspects of transplantation from various perspectives, enabling attendees to gain insights from multiple angles and fostering a broader appreciation of the field's complexities.
- Synergy - Transplantation involves numerous stakeholders, including clinicians, researchers, patients, policymakers, industry professionals, media and advocacy groups. The integration of diverse perspectives and expertise will be a unique opportunity for participants facilitating the development of comprehensive strategies and policies to enhance transplantation outcomes globally.
- Looking to the future - Participants will be challenged to think critically about the future of transplantation. The Inform theme ensures the dissemination of up-to-date knowledge, while the Transform theme promotes innovation and the exploration of new frontiers. The Sustain theme directs our attention to what long-term success looks like for the field, including ethical considerations, patient outcomes, and resource management. This forward-looking approach will inspire attendees to envision the future of transplantation and work collectively towards its realization.
Registration Now Open!
Hotel Reservation Now Open!
Week-at-a-Glance
Official Airline
Turkish Airlines is the official airline for TTS 2024. Special discounts are offered for all delegates travelling via international flights arriving in Istanbul.
Our inaugural lineup of Thematic Session speakers represents the forefront of transplantation research and practice. Engage with trailblazing minds, gain insights, and explore cutting-edge advancements in the field. Don't miss this unparalleled opportunity at TTS 2024!
Monday - September 23
Monday - September 23
| 15:40 - 16:40 | Thematic Session: Genetics in precision medicine |
|
Genetics for precision medicine in transplantation Shane T Grey, Australia |
|
Biopsy transcriptomics for diagnosis and research Jasper Callemeyn, Belgium |
|
Identifying operational tolerance Sophie Brouard, France |
| 15:40 - 16:40 | Thematic Session: Promises of big data and AI - facts or fiction? |
|
Machine learning model for outcome prediction Nancy Kwan Man, Hong Kong |
|
Application of AI in transplant pathology Weijia Zhang, United States |
|
Developing transplant registries in LMIC and MIC Adisorn Lumpaopong, Thailand |
| 15:40 - 16:40 | Thematic Session: Uterus-transplantation: Where are we now |
|
10 years after the first successful uterus transplant: How will the
teenage years look? Mats Brannstrom, Sweden |
|
Ethical guardrails in uterus transplantation Anji Wall, United States |
|
Uterus-specific aspects of alloimmunity and immunosuppression Paige Porrett, United States |
| 15:40 - 16:40 | Thematic Session: Clinical trials design and end-points in transplantation |
|
Innovative trial design in transplantation Andrea Viecelli, Australia |
|
The Parsons Model - ethical implications of research involving
those determined dead by neurological criteria Jayme Locke, United States |
|
Trials in immunosuppression/Long term in kidney transplantation Roslyn B. Mannon, United States |
| 15:40 - 16:40 | Thematic Session: Organ utilization - do we need to challenge each other to do better? |
|
The promise of equity in a deceased donor allocation system Chris Callaghan, United Kingdom |
|
Strategies to improve non-utilisation rates of deceased donors Sumit Mohan, United States |
|
Reducing the risk of donor transmitted disease Beatriz Dominguez-Gil, Spain |
| 15:40 - 16:40 | Thematic Session: Life participation and living well after transplantation |
|
Living well after transplantation Bill Wang, Hong Kong |
|
Work, life, and sex after transplantation Louise Lerminiaux, Costa Rica |
|
Prehabilitation into transplant and beyond Marieke Vandecruys, Belgium |
| 15:40 - 16:40 | Thematic Session: Pancreas and islet |
|
Beta cell replacement (whole pancreas, islet and cell
transplantation) within the treatment landscape of type 1
diabetes Braulio Alejandro Marfil-Garza, Mexico |
|
Deciphering the immunological enigma of allo-beta cell
transplantation: Addressing unresolved questions and embracing the
frontiers of knowledge Lorenzo Piemonti, Italy |
Tuesday - September 24
Tuesday - September 24
| 15:40 - 16:40 | Thematic Session: Advances in antibody assessment |
|
ABO antibodies - future perspectives Lori J. West, Canada |
|
Advances in AB detection: From Luminex to Eplets and more Cynthia Kramer, Netherlands |
| 15:40 - 16:40 | Thematic Session: Equity and access to transplantation |
|
Risks to equity in organ allocation introduced by AI Mamatha Bhat, Canada |
|
Disparity in access to solid organ transplantation Lungiswa Mtingi-Nkonzombi, South Africa |
|
Sex and gender disparities in transplantation access Bethany Foster, Canada |
| 15:40 - 16:40 | Thematic Session: Reproductive care - General |
|
Gestational outcomes for transplant recipients: A focus on fetal
health Margriet FC de Jong, Netherlands |
|
Impact of pregnancy on graft function in kidney Tx Marleen van Buren, Netherlands |
|
Reproductive planning - why & how Shilpanjali Jesudason, Australia |
| 15:40 - 16:40 | Thematic Session: Cellular therapies |
|
Dendritic cells - insights from clinical trials Angus W Thomson, United States |
|
CAR-Treg optimization Mohsen Khosravi-Maharlooei, United States |
|
Adoptive t-cell therapy for infections Patrizia Comoli, Italy |
| 15:40 - 16:40 | Thematic Session: Organ perfusion and preservation |
|
Novel delivery of cellular therapy to reduce ischemia reperfusion
injury in kidney transplantation Emily R. Thompson, United Kingdom |
|
Ex-situ machine perfusion (heart, liver, kidney) (standard,
oxygenated, hypothermic, normothermic) Gabriel Oniscu, Sweden |
|
Cryopreservation Erik Finger, United States |
| 15:40 - 16:40 | Thematic Session: Dealing with post-transplant complications |
|
De novo malignancy post-transplant Naoka Murakami, United States |
|
What's new in vaccines? Andrew Karaba, United States |
|
Managing post-transplant metabolic disease Wai Lim, Australia |
| 15:40 - 16:40 | Thematic Session: Kidney transplant surgery |
|
The best way to procure live donor kidneys: Robotic vs.
laparoscopic donor nephrectomy Chandra Bhati, United States |
|
Robotic renal transplantation: State of the art Sangil Min, Korea |
|
Robotic renal transplantation: A niche approach for selected
patients or the future surgical approach for all? Timucin Taner, United States |
Wednesday, September 25
Wednesday, September 25
| 15:25 - 16:25 | Thematic Session: Surfing the big data wave |
|
Patient centred outcomes measures Nicole J Scholes-Robertson, Australia |
|
Genomics strategies to redefine histocompatibility and risk
stratification Sophie Limou, France |
|
Is AI better than human in predicting post-transplant outcomes? Carmen Lefaucheur, France |
| 15:25 - 16:25 | Thematic Session: Regenerative medicine |
|
Regenerative medicine in cardiology James Chong, Australia |
|
Overcoming senescence to improve transplant outcome Anette Melk, Germany |
| 15:25 - 16:25 | Thematic Session: Patient-centered care |
|
Ready-Steady-Go/A blueprint for health care transition in
Europe? Arvind Nagra, United Kingdom |
|
The therapy in wellness, movement and community Liz Schick, United Kingdom |
| 15:25 - 16:25 | Thematic Session: Normothermic regional perfusion (A-NRP and TA-NRP) |
|
Implications of NRP and especially TA-NRP for death
determination Dale Gardiner, United Kingdom |
|
|
The surgical approach - the US perspective Anji Wall, United States |
|
The surgical approach - the Spanish perspective Alicia Pérez, Spain |
| 15:25 - 16:25 | Thematic Session: Infection complications in transplantation |
1
|
Climate change and Infection - how it affects transplantation Ilan Schwartz, United States |
2
|
COVID-19 infections and impact on transplant outcomes in the
Middle-East Sibel G. Gocay Bek, Turkey |
3
|
Recurrent UTI in solid organ transplant recipient Deepali Kumar, Canada |
| 15:25 - 16:25 | Thematic Session: Minimally invasive recipient surgery: The future is here (Liver) |
|
How far can we expand the indication of Robot-assisted LDLT? Dieter C. Broering, Saudi Arabia |
|
Which is better for graft extraction/insertion? Upper midline
incision vs, Pfannenstiel incision Mohamed Rela, India |
|
Which is better for graft explant and/or graft implantation?
Laparoscopic vs. Robot Assisted Kwang-Woong Lee, Korea |
| 15:25 - 16:25 | Thematic Session: Xenotransplantation’s regulatory road to the clinic |
|
History of Xenotransplantation and moving to clinical practice Wayne Hawthorne, Australia |
|
WHO leadership in developing global strategies for
xenotransplantation Efstratios (Stratos) Chatzixiros, Switzerland |
|
Moving forward to ensure continuing registration of clinical
Xenotransplantation Leo Hans Buhler, Switzerland |
Times listed are in the Istanbul time zone. Visit the WebApp if you are attending virtual to see your local time.
